RxDoctor Payments Data

Peggy Ann Garjian

Rheumatology · Staten Island, NYNPI 1386755817

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,420 of the $8,248 with a category attached, or 90.0%. It is spread thinly across 20 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,147 and has fallen 80.9% since, to $602 in 2023.

$8,248in general payments, 2019–2025

Across 381 payments — averaging $21.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$2K
  • Mallinckrodt Enterprises LLC$1K
  • Amgen$1K
  • AbbVie$1K
  • Lilly USA, LLC$660
  • GSK$578
  • plus $2K from 14 others

What the payments were for

  • Consulting fees$80010%
  • Food & beverage$7,42090%
  • Education$280%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,248 in reported general payments places this provider in the 70th percentile of 541 rheumatology providers in New York.

See all rheumatology providers in New York →

Other rheumatology in Staten Island

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →